NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Thursday that its first quarter revenues rose 4 percent year over year, thanks largely to high demand for certain molecular diagnostic services that pushed its clinical lab revenues up 9 percent during the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.